Article

StealthX: A Versatile and Potent Exosome Based Vaccine Platform for the Next Pandemic

2025-11-12

Abstract excerpt

Exosome-based vaccines represent a transformative platform in modern vaccinology, combining nanoscale delivery, biocompatibility, and potent immunogenicity. Among these, the StealthX platform developed by Capricor, Inc has demonstrated exceptional versatility, enabling antigen presentation at nanogram level doses without the need for adjuvants. Preclinical studies using StealthX have shown strong humoral and cellu...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 255d1a8e-b3c3-5284-9c79-4d35a43284ea
DOI: 10.20944/preprints202511.0826.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

StealthX: A Versatile and Potent Exosome Based Vaccine Platform for the Next PandemicDOI 10.20944/preprints202511.0826.v1Read

Exosome-Based Multivalent Vaccine: Achieving Potent Immunization, Broadened Reactivity, and Strong T-Cell Responses with Nanograms of ProteinsSemantic proximity Read

Nanograms of SARS-CoV-2 spike protein delivered by exosomes induce potent neutralization of both delta and omicron variantsSemantic proximity Read

Exosome based multivalent vaccine: achieving potent immunization, broadened reactivity, and strong T cell responses with nanograms of proteinsSemantic proximity Read

Nanograms of SARS-CoV-2 Spike Protein Delivered by Exosomes Induce Potent Neutralization of Both Delta and Omicron VariantsSemantic proximity Read

Exosome-Mediated mRNA Delivery For SARS-CoV-2 VaccinationSemantic proximity Read

Development of an engineered extracellular vesicles-based vaccine platform for combined delivery of mRNA and protein to induce functional immunitySemantic proximity Read

Exosome-Mediated Antigen Delivery: Unveiling Novel Strategies in Viral Infection Control and Vaccine DesignSemantic proximity Read

Exosome-based vaccines and their position in next generation vaccinesSemantic proximity Read

ESCRT recruitment to SARS-CoV-2 spike induces virus-like particles that improve mRNA vaccinesSemantic proximity Read

The Unique Features and Collateral Immune Effects of mRNA-Based COVID-19 Vaccines: Potential Plausible Causes of Adverse Events and ComplicationsSemantic proximity Read

Elasomeran (mRNA1273) Vaccine: The Journey from Preclinical Research to Clinical Trials, Authorization, and FDA ApprovalSemantic proximity Read

Promising Extracellular Vesicle-Based Vaccines against Viruses, Including SARS-CoV-2Semantic proximity Read